[{"Assets_0_FY_USD":2229400000.0,"CommonStockSharesOutstanding_0_FY_shares":51200000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":41800000.0,"NetIncomeLoss_4_FY_USD":62700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":50100000.0,"EarningsPerShareBasic_4_FY_USD":1.25,"Ticker":"EBS","CIK":"1367644","name":"EMERGENT BIOSOLUTIONS INC.","OfficialName":"Emergent Biosolutions Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2077670312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190222"}]